Matthew Wiley
Corporate Officer/Principal bij BIOXCEL THERAPEUTICS, INC.
Vermogen: 8 437 $ op 31-03-2024
Profiel
Matthew T.
Wiley is currently the Chief Commercial Officer & Senior Vice President at BioXcel Therapeutics, Inc. He previously worked as the Vice President-Marketing at Jazz Pharmaceuticals, Inc. from 2012 to 2018, and as the Chief Commercial Officer at VYNE Pharmaceuticals Ltd.
from 2018 to 2020.
He also served as the Chief Commercial Officer at Menlo Therapeutics, Inc. and as the Vice President-Marketing at Jazz Pharmaceuticals Commercial Corp.
from 2007 to 2012.
Mr. Wiley received his undergraduate degree from Syracuse University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-04-2024 | 2 992 ( 0.01% ) | 8 437 $ | 31-03-2024 |
Actieve functies van Matthew Wiley
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Corporate Officer/Principal | 19-01-2022 |
Eerdere bekende functies van Matthew Wiley
| Bedrijven | Functie | Einde |
|---|---|---|
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Corporate Officer/Principal | 09-03-2020 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Sales & Marketing | 01-01-2018 |
Jazz Pharmaceuticals Commercial Corp.
 Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals Commercial Corp. provides pharmaceutical services. It engages in identifying, developing, and commercializing products in the areas of CNS, women's health, and urology. The company was founded in 2005 and is headquartered in Philadelphia, PA. | Sales & Marketing | 01-01-2012 |
| VYNE THERAPEUTICS INC. | Corporate Officer/Principal | - |
| VYNE THERAPEUTICS INC. | Corporate Officer/Principal | - |
Opleiding van Matthew Wiley
| Syracuse University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| VYNE THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals Commercial Corp. provides pharmaceutical services. It engages in identifying, developing, and commercializing products in the areas of CNS, women's health, and urology. The company was founded in 2005 and is headquartered in Philadelphia, PA. | Health Technology |
